Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;37(17):4569-4579.
doi: 10.1080/07391102.2018.1554510. Epub 2019 Jan 2.

Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox: part II

Danielle Rodrigues Garcia  1 , Felipe Rodrigues de Souza  1 , Ana Paula Guimarães  2 , Teodorico Castro Ramalho  3   4 , Alcino Palermo de Aguiar  5 , Tanos Celmar Costa França  1   4
Affiliations

Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox: part II

Danielle Rodrigues Garcia et al. J Biomol Struct Dyn. 2019 Oct.

Abstract

Acknowledging the importance of studies toward the development of measures against terrorism and bioterrorism, this study aims to contribute to the design of new prototypes of potential drugs against smallpox. Based on a former study, nine synthetic feasible prototypes of selective inhibitors for thymidylate kinase from Variola virus (VarTMPK) were designed and submitted to molecular docking, molecular dynamics simulations and binding energy calculations. The compounds are simplifications of two more complex scaffolds, with a guanine connected to an amide or alcohol through a spacer containing ether and/or amide groups, formerly suggested as promising for the design of selective inhibitors of VarTMPK. Our study showed that, despite the structural simplifications, the compounds presented effective energy values in interactions with VarTMPK and HssTMPK and that the guanine could be replaced by a simpler imidazole ring linked to a -NH2 group, without compromising the affinity for VarTMPK. It was also observed that a positive charge in the imidazole ring is important for the selectivity toward VarTMPK and that an amide group in the spacer does not contribute to selectivity. Finally, prototype 3 was pointed as the most promising to be synthesized and experimentally evaluated. Communicated by Ramaswamy H. Sarma.

Keywords: Drug design; Variola virus; docking; molecular dynamics simulations; smallpox; thymidylate kinase.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
Selected structures proposed by Guimarães and coworkers (2015) as inhibitors for VarTMPK.
Figure 2.
Figure 2.
Structures of the proposed prototypes.
Figure 3.
Figure 3.
Best molecular docking poses for prototype 3 inside (a) VarTMPK and (b) HssTMPK. Interacting residues are shown in different colors, and residues belonging to the active site are labeled in red..
Figure 4.
Figure 4.
RMSD for the systems formed between the enzymes (in black) and prototype 2 (in red). Left: VarTMPK/prototype 2; right: HssTMPK/prototype 2.
Figure 5.
Figure 5.
RMSD for the systems formed between the enzymes (in black) and prototype 3 (in red). Left: VarTMPK/prototype 3; right: HssTMPK/prototype 3.
Figure 6.
Figure 6.
RMSD for the systems formed between the enzymes (in black) and prototype 4 (in red). Left: VarTMPK/prototype 4; right: HssTMPK/prototype 4.
Figure 7.
Figure 7.
RMSD for the systems formed between the enzymes (in black) and prototype 9 (in red). Left: VarTMPK/prototype 9; right: HssTMPK/prototype 9.
Figure 8.
Figure 8.
Plots of mean H-bonds formed by prototypes 3 (left) and 9 (right) inside VarTMPK during the 100 ns of MD simulation.
Figure 9.
Figure 9.
Main interactions of the complexes of VarTMPK/prototype 3 (left) and HssTMPK/prototype 3 (right) calculated by MM-PBSA.
Figure 10.
Figure 10.
Main interactions of the complexes of VarTMPK/prototype 9 (left) and HssTMPK/prototype 9 (right) calculated by MM-PBSA.
See this image and copyright information in PMC

References

    1. Abraham, M. J., Murtola, T., Schulz, R., Pall, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS High performance molecular simulations through multi-level parallelism from laptops to supercomputers. Software X, 1-2,19–25. doi: 10.1016/j.softx.2015.06.001 - DOI
    1. Almeida, J. S. D., Guizado, T. R. C., Guimarães, A. P., Ramallho, T. C., Goncalves, A. S., Koning, M. C., & Franca, T. C. C. (2015). Docking and molecular dynamics studies of peripheral site ligand-oximes as reactivators of sarin-inhibited human acetylcholinesterase. Journal of Biomolecular Structure and Dynamics, 34,2632–2642. doi: 10.1080/07391102.2015.1124807 - DOI - PubMed
    1. Almeida, J. S. F. D., Cavalcante, S. F. A., Dolezal, R., Kuca, K., Musilek, K., Jun, D., & Franca, T. C. C. (2018). Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with the peripheral anionic site (PAS) of human acetylcholinesterase. Journal of Biomolecular Structure and Dynamics, 1–8 [published online]. doi: 10.1080/07391102.2018.1475259 - DOI - PubMed
    1. Bastos, L. C., Souza, F. R., Guimarães, A. P., Sirouspour, M., Guizado, T. R. C., Forgione, P., … Franca, T. C. C. (2016). Virtual screening, docking and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis. Journal of Biomolecular Structure and Dynamics, 34(10),2184–2198. 2016. doi: 10.1080/07391102.2015.1110832 - DOI - PubMed
    1. Berendsen, H. J. C., Van Der Spoel, D., & Van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3),43–56. doi: 10.1016/0010-4655(95)00042-E - DOI

Publication types

MeSH terms